Company news
Transmedics Group, Inc. (NASDAQ:TMDX) news
Transmedics Group, Inc. news releases on 6ix. Latest, Sep 10, 2026: TransMedics Appoints Fernando Araujo as Chief Financial Officer and Reiterates 2026…
Press releases & updates
TransMedics Appoints Fernando Araujo as Chief Financial Officer and Reiterates 2026 Financial Outlook
September 10, 2026
TransMedics Reports Second Quarter 2026 Financial Results
August 4, 2026
TransMedics to Present at the Canaccord Genuity 46th Annual Growth Conference
July 28, 2026
TransMedics to Report Second Quarter 2026 Financial Results on August 4, 2026
July 21, 2026
TransMedics Group Announces Completion of Strategic Investment in PAD Aviation service GmbH
July 6, 2026
Normothermic Machine Perfusion Market is Going to Booming Growth 2026-2033 | TransMedics Group Inc, OrganOx Limited
May 7, 2026
TransMedics Reports First Quarter 2026 Financial Results
May 5, 2026
TransMedics Group Announces Intent to Create the First Dedicated European Transplant Logistics Network with Strategic Investment in PAD Aviation service GmbH
April 29, 2026
TransMedics to Provide Update on Ongoing Clinical Programs at the International Society of Heart and Lung Transplantation 2026 Annual Meeting
April 23, 2026
TransMedics to Report First Quarter 2026 Financial Results on May 5, 2026
April 21, 2026
TransMedics Provides Additional Information on the Impact of the Release of the Valuation Allowance on Deferred Tax Assets on Previously Reported Fourth Quarter Financial Results
February 26, 2026
TransMedics Reports Fourth Quarter and Full Year 2025 Financial Results
February 24, 2026
TransMedics to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
February 10, 2026
TransMedics Receives Full and Unconditional FDA IDE Approval for Next-Generation OCS Heart ENHANCE Trial
February 9, 2026
BioMed Realty and TransMedics Announce 498,000-Square-Foot Lease at Assembly Innovation Park
January 12, 2026
TransMedics Announces New Global Headquarters and Expansion at Assembly Innovation Park in Somerville, Massachusetts
January 12, 2026
TransMedics to Participate in the 44th Annual J.P. Morgan Healthcare Conference
December 29, 2025
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
December 23, 2025
TransMedics to Participate in the Piper Sandler 37th Annual Healthcare Conference
November 17, 2025
TransMedics Reports Third Quarter 2025 Financial Results
October 28, 2025
TransMedics to Report Third Quarter 2025 Financial Results on October 29, 2025
October 14, 2025
TransMedics and Mercedes-Benz Announce Strategic Collaboration to Launch First Dedicated Organ Transplantation Ground Transportation Network in Italy
September 21, 2025
TransMedics to Present at Upcoming September Investor Conferences
August 24, 2025
TransMedics Receives FDA IDE Approval to Initiate Next-Generation OCS Heart Trial
August 3, 2025
TransMedics Reports Second Quarter 2025 Financial Results
July 29, 2025
TransMedics to Present at the Canaccord Genuity 45th Annual Growth Conference
July 28, 2025
TransMedics to Report Second Quarter 2025 Financial Results on July 30, 2025
July 15, 2025
TransMedics to Present at Upcoming June Investor Conferences
May 19, 2025
TransMedics Reports First Quarter 2025 Financial Results
May 7, 2025
TransMedics to Report First Quarter 2025 Financial Results on May 8, 2025
April 23, 2025
TransMedics Reports Fourth Quarter and Full Year 2024 Financial Results
February 26, 2025
TransMedics to Present at Upcoming March Investor Conferences
February 17, 2025
TransMedics to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025
February 12, 2025
TransMedics Responds to Inaccurate and Misleading Claims in Recent Short-Seller Report
January 12, 2025
TransMedics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
December 22, 2024
TransMedics Appoints Gerardo Hernandez as Chief Financial Officer and Provides Updated 2024 Financial Outlook
December 1, 2024
TransMedics to Host Investor & Analyst Day on December 10, 2024
November 25, 2024
TransMedics to Participate in the Piper Sandler 36th Annual Healthcare Conference
November 18, 2024
TransMedics Reports Third Quarter 2024 Financial Results
October 27, 2024
TransMedics to Report Third Quarter 2024 Financial Results on October 28, 2024
October 14, 2024
TransMedics to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
August 20, 2024
TransMedics Reports Second Quarter 2024 Financial Results
July 30, 2024
TransMedics to Present at the Canaccord Genuity 44th Annual Growth Conference
July 28, 2024
TransMedics to Report Second Quarter 2024 Financial Results on July 31, 2024
July 16, 2024
TransMedics Reports First Quarter 2024 Financial Results
April 29, 2024
TransMedics to Report First Quarter 2024 Financial Results on April 30, 2024
April 15, 2024
TransMedics Reports Fourth Quarter and Full Year 2023 Financial Results
February 25, 2024
TransMedics to Report Fourth Quarter and Full Year 2023 Financial Results on February 26, 2024
February 11, 2024
TransMedics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
December 17, 2023
TransMedics to Present at the Piper Sandler 35th Annual Healthcare Conference
November 13, 2023